Versuchen GOLD - Frei

Foxconn saga: Total recall

Business Standard

|

July 07, 2025

The Foxconn order — to send back Chinese workers from India's iPhone plants — is among the many steps taken by China to hit India's manufacturing sector

- SURAJEET DAS GUPTA

At a time when the automobile industry is coping with the shortage of heavy rare earth magnets, sourced primarily from China, Taiwanese contract manufacturer Foxconn Hon Hai has delivered a blow to manufacturing of Apple products in India.

Ahead of the iPhone 17 launch, which was supposed to have brought India center stage in Apple's global supply chain, Foxconn has ordered hundreds of Chinese technicians and engineers to leave the Indian factories and return home.

While there's no official reason for the recall, people in the know explained that it was at the behest of the Chinese government, which has a hold over the Taiwanese firm.

For Foxconn, which is the biggest iPhone assembler for the Cupertino major, China accounts for 65-70 percent of its total revenues. In fact, half of Foxconn's long-term assets are located in China.

Foxconn has maintained silence on the matter.

Amid the geopolitical disruptions, experts watching this space believe that the recall of workers is just one aspect in a multi-pronged Chinese onslaught on India.

The aim is to disrupt the country's attempt and initial success to offer an alternative competitive global supply chain to multinationals as part of the China plus strategy.

The move should be seen against the backdrop of the possibility of the United States imposing higher tariffs on China compared to India, experts pointed out.

If that happens, Indian electronics exports would get a major boost—something China would want to prevent.

China has already tried to block big government-supported infrastructure projects by stopping exports of tunnel boring machines to India.

Those machines are crucial for the bullet train project and metro rail expansion, among others.

The current automobile industry crisis adds to the onslaught.

WEITERE GESCHICHTEN VON Business Standard

Business Standard

Labour Codes impact: HCL tech profit slips 11%

Q3 top line beats Street estimates, bottom line misses expectations

time to read

2 mins

January 13, 2026

Business Standard

New labour Codes, restructuring weigh on TCS earnings

Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Black drives the thrill for car buyers

Sees a surge in yearly sales, while white remains practical 'utility king'

time to read

2 mins

January 13, 2026

Business Standard

CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS

Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be

time to read

2 mins

January 13, 2026

Business Standard

Business Standard

China’s PVC rethink to help India pipe makers

Supply likely to tighten after S-PVC rebate withdrawal

time to read

2 mins

January 13, 2026

Business Standard

Responsible growth

India must ensure data centres are sustainable

time to read

2 mins

January 13, 2026

Business Standard

India’s GenZ is full of creativity: PM

Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Iran wants to negotiate after threats to attack, says Trump

At least 572 killed in protests; Tehran says situation ‘under full control’

time to read

2 mins

January 13, 2026

Business Standard

Insurers knock on Irdai door for clarity on director overlap ban

CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY

time to read

2 mins

January 13, 2026

Business Standard

Delhi HC allows Zydus to sell generic version of cancer drug

Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.

time to read

1 min

January 13, 2026

Listen

Translate

Share

-
+

Change font size